11.20.2023
Improve Outcomes
$1,217,662.00
18 months
A randomized crossover trial evaluating the effect of inhaled Technosphere Insulin versus rapid acting analogue insulin on exercise-induced hypoglycemia in adults with T1D using automated insulin delivery
A randomized crossover trial evaluating the effect of inhaled Technosphere Insulin versus rapid acting analogue insulin on exercise-induced hypoglycemia in adults with T1D using automated insulin delivery